MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-20-0023573
Alentica Pharmaceuticals Private Limited
Alentica Pharmaceuticals Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.83 Cr
▲ 16% YoY
Net profit · FY 2025
₹34.27 Lakh
Net margin 8.9%
EBITDA · FY 2025
₹51.38 Lakh
EBITDA margin 13.4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Alentica Pharmaceuticals Private Limited
Data last updated:
Alentica Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 October 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2017PTC120238. Its GSTIN is 36AAQCA1674D1ZN (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vadde Swetha and Santhosh Reddy Vadde.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 17P/18P Dwarka Nagar Boduppal, Hyderabad, Telangana, India – 500039.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.83 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹34.27 Lakh (net margin 8.9%) and EBITDA of ₹51.38 Lakh (EBITDA margin 13.4%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 22% over five years.
Alentica Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0023573). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24100TG2017PTC120238
Registration Number 120238
Incorporation Date 25 October 2017
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TS-20-0023573
Recognitions & Rankings of Alentica Pharmaceuticals
Contact details
Alentica Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address17P/18P Dwarka Nagar Boduppal, Hyderabad, Telangana, India – 500039
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Alentica Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Alentica Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Alentica Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Alentica Pharmaceuticals Private Limited, buy the company report.
Financials of Alentica Pharmaceuticals Private Limited
FY 2025 filings availableAlentica Pharmaceuticals Private Limited reported revenue of ₹3.83 Cr (up 16% YoY) for FY 2025.
Revenue · FY 2025
₹3.83 Cr ▲ 16%
Net profit · FY 2025
₹34.27 Lakh margin 8.9%
EBITDA · FY 2025
₹51.38 Lakh margin 13.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 16%
3 years · compounded
▲ 18%
5 years · compounded
▲ 22%
EBITDA CAGR growth
1 year
▲ 23%
3 years · compounded
▲ 35%
5 years · compounded
▲ 48%
Revenue has grown at a compounded annual rate (CAGR) of 22% over five years, including 16% growth in the latest year. EBITDA rose 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹51.38 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹34.27 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.4% | ||||
| Net Profit Margin | 8.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Alentica Pharmaceuticals Private Limited, buy the company report.
Board of directors of Alentica Pharmaceuticals Private Limited
Alentica Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vadde Swetha Also directs: Clarida Pharma Private Limited | Director | 25 Oct 2017 | 9 Years 0 Months | Current |
| Santhosh Reddy Vadde | Director | 01 Aug 2018 | 8 Years 3 Months | Current |
Peer comparison
Alentica Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dial Pharmaceuticals Private Limited | ₹3.84 Cr (FY 2025) | -3.0% | Ahmedabad, Gujarat, India | |||
| Dharuhera Pharmaceuticals Pvt Ltd | ₹3.83 Cr (FY 2025) | -79.0% | New Delhi, Delhi, India | |||
| Alentica Pharmaceuticals Private Limitedthis company | ₹3.83 Cr (FY 2025) | ₹34.27 Lakh | 8.9% | 16.0% | Hyderabad, Telangana, India | |
| Madhav Drugs Private Limited | ₹3.83 Cr (FY 2025) | 5.0% | Delhi, India | |||
| Wellbert Pharmaceuticals (Bombay) Pvt Ltd | ₹3.81 Cr (FY 2017) | 45.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Alentica Pharmaceuticals Private Limited, buy the company report.
Auditor
Alentica Pharmaceuticals Private Limited is audited by THEJONATH & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| THEJONATH & ASSOCIATES | FY 2020 | 017275S |
Shareholding
The shareholding of Alentica Pharmaceuticals Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Alentica Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Alentica Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Alentica Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Alentica Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAQCA1674D1ZN | Telangana | Active | 08 Dec 2017 |
To see the full GST registrations and return filing status of Alentica Pharmaceuticals Private Limited, buy the company report.
Recent activity
Alentica Pharmaceuticals Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Santhosh Reddy Vadde was appointed as Director on 01 Aug 2018.
AGM
Alentica Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Alentica Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Santhosh Reddy Vadde was appointed as Director.
Ceased
Satyanarayana Reddy Vadde ceased to be Director.
Appointed
Vadde Swetha was appointed as Director.
Incorporation
25 Oct 2017
Alentica Pharmaceuticals Private Limited was registered on 25 Oct 2017 with Roc Hyderabad & aged 9 years 18 days as per MCA records.
Frequently asked questions
Alentica Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 October 2017 (9+ years old) and is registered under CIN U24100TG2017PTC120238.
Alentica Pharmaceuticals has 2 current directors:
- Vadde Swetha - Director
- Santhosh Reddy Vadde - Director
The latest financial statements of Alentica Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Alentica Pharmaceuticals is 36AAQCA1674D1ZN, registered in Telangana.
The CIN (Corporate Identification Number) of Alentica Pharmaceuticals is U24100TG2017PTC120238. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alentica Pharmaceuticals was incorporated on 25 October 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Alentica Pharmaceuticals by revenue are Dial Pharmaceuticals Private Limited, Dharuhera Pharmaceuticals Pvt Ltd, Madhav Drugs Private Limited, Wellbert Pharmaceuticals (Bombay) Pvt Ltd, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Santhosh Reddy Vadde was appointed as Director on 01 Aug 2018. Satyanarayana Reddy Vadde ceased to be Director on 01 Aug 2018. Vadde Swetha was appointed as Director on 25 Oct 2017.
Yes, Alentica Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-20-0023573).
The registered office of Alentica Pharmaceuticals is at 17P18P Dwarka Nagar Boduppal, Hyderabad, Telangana, India – 500039.
Alentica Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages